Study of the Rate of Progression of Cerebral Ischemia in Afro-Caribbeans
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de la Guadeloupe
About this trial
To compare the progression of cerebral ischemia from HF in Afro-Caribbean patients admitted to the CHUG to that of patients from Nantes included in the national ETIS registry.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 and over, admitted for IC due to LVO verified by medical imaging and hospitalized in neurology.
Patients residing in Guadeloupe
Afro-Caribbean patients: of African ancestry.
Emergency inclusion, with exemption from obtaining consent due to the immediate life-threatening emergency situation of the patient (Article L1122-1-3 of the French Public Health Code); as soon as possible, consent to continue will be sought from the patient or, if applicable, from a relative or a trusted person.
Disqualifiers
Patients under 18 years old
Non-resident patients in Guadeloupe
Protected persons (articles L1121-5, L1121-6 and L121-8 of the Public Health Code): pregnant or breastfeeding women, persons deprived of their liberty, under guardianship or curatorship)
Withdrawal of consent during the study
Trial population
patients with a diagnosis of stroke from LVO identified by medical imaging
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No Interventions
Other interventionNo interventions
Treatment groups
135 Participants
are divided into 2 treatment groupsGroup A: Patients residing in Guadeloupe1 intervention
Group B: Patients residing in Nantes1 intervention
Trial outcomes
Primary outcomes
1
progression of cerebral ischemia of IC in Afro-Caribbean patients admitted to the CHUG with that of patients from Nantes included in the national register ETIS
Compare the progression of cerebral ischemia of IC in Afro-Caribbean patients admitted to the CHUG with that of patients from Nantes included in the national register ETIS
Time frame
baseline, day 1,2,3,4 an day 90Secondary outcomes
1
Characterizing the profile of Afro-Caribbean patients
1\. the collateral imaging substitutions in patients of CHUG and CHU de Nantes. The collateral network will be evaluated either by perfusion imaging (Tmax \> 6s) or by digitized arterial angiography in a thrombectomy room on the day of stroke according to the ASITN/SIR classification (J0).
Time frame
baseline2
Characterizing the profile of Afro-Caribbean patients
impact of environmental conditions on ischemia progression rate at Guadeloupe Hospital
Time frame
baseline3
Characterizing the profile of Afro-Caribbean
the effect of ischemia-reperfusion induced inflammatory response on ischemia volume
Time frame
at the end of the sutySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: